| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUCUAUCGACGAGUCUGGUAGCUGAGCGUUGGGCUGUAGGUCGCUGUGC… | 2140 nt | 0.4280 | |
| AUUCUCCUGCCUCAGCCUCCCGAGUAGCUGGGACUACAGGCGCAUGUUU… | 2145 nt | 0.4135 | |
| AUUCUCCUGCCUCAGCCUCCCGAGUAGCUGGGACUACAGGCGCAUGUUU… | 2062 nt | 0.4132 | |
| CUCUAUCGACGAGUCUGGUAGCUGAGCGUUGGGCUGUAGGUCGCUGUGC… | 2044 nt | 0.4291 | |
| CUCUAUCGACGAGUCUGGUAGCUGAGCGUUGGGCUGUAGGUCGCUGUGC… | 2035 nt | 0.4280 | |
| CUCUAUCGACGAGUCUGGUAGCUGAGCGUUGGGCUGUAGGUCGCUGUGC… | 2057 nt | 0.4283 | |
| CUCUAUCGACGAGUCUGGUAGCUGAGCGUUGGGCUGUAGGUCGCUGUGC… | 2209 nt | 0.4233 |
The protein encoded by this gene is an enzyme that contains both hydrolase and aminopeptidase activities. The hydrolase activity is used in the final step of the biosynthesis of leukotriene B4, a proinflammatory mediator. The aminopeptidase activity has been shown to degrade proline-glycine-proline (PGP), a neutrophil chemoattractant and biomarker for chronic obstructive pulmonary disease (COPD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
A study in humans demonstrated that the LTA4H mRNA in salivary extracellular vesicles was significantly upregulated in emergency department patients with acute traumatic brain injury compared to healthy participants [Cheng et al. DOI:10.4103/1673-5374.266924].